Literature DB >> 10622235

Mechanism of the aspirin-induced rise in blood alcohol levels.

R T Gentry1, E Baraona, I Amir, R Roine, Z W Chayes, R Sharma, C S Lieber.   

Abstract

Aspirin increases blood alcohol levels after post-prandial alcohol consumption in men. This was attributed to a decrease in first pass metabolism secondary to inhibition of gastric alcohol dehydrogenase. Since accelerated gastric emptying, decreased volume of distribution or delayed elimination could also result in higher blood alcohol levels, we investigated the effect of aspirin (1 g taken with a meal) on these parameters. Aspirin did not change the volume of ethanol distribution or the rate of its elimination. Moreover, it did not have a significant effect on gastric emptying. The half-time of 99Tc-DTPA loss was 65.5+/-5.4 minutes without and 71.3+/-6.5, with aspirin. Despite a trend for slower gastric emptying with aspirin, the alcohol bioavailability increased and was associated with a 39% decrease in the first pass metabolism of alcohol (from 106+/-4 to 65+/-19 mg/kg, p<0.05), consistent with the inhibition of gastric ADH activity. In keeping with this interpretation, the effect of aspirin was virtually absent in women, who have a much smaller first pass metabolism available for inhibition by aspirin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10622235     DOI: 10.1016/s0024-3205(99)00517-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

Review 1.  Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.

Authors:  Ake Norberg; A Wayne Jones; Robert G Hahn; Johan L Gabrielsson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

3.  Aspirin impairs acetyl-coenzyme A metabolism in redox-compromised yeast cells.

Authors:  Gianluca Farrugia; Maria Azzopardi; Christian Saliba; Godfrey Grech; Angelina S Gross; Jelena Pistolic; Vladimir Benes; Neville Vassallo; Joseph Borg; Frank Madeo; Tobias Eisenberg; Rena Balzan
Journal:  Sci Rep       Date:  2019-04-16       Impact factor: 4.379

Review 4.  Combination drug use and risk for fetal harm.

Authors:  Weijung A Chen; Susan E Maier
Journal:  Alcohol Res Health       Date:  2011

5.  The nanomolar sensing of nicotinamide adenine dinucleotide in human plasma using a cycling assay in albumin modified simulated body fluids.

Authors:  Philipp Brunnbauer; Annekatrin Leder; Can Kamali; Kaan Kamali; Eriselda Keshi; Katrin Splith; Simon Wabitsch; Philipp Haber; Georgi Atanasov; Linda Feldbrügge; Igor M Sauer; Johann Pratschke; Moritz Schmelzle; Felix Krenzien
Journal:  Sci Rep       Date:  2018-10-31       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.